This, in turn, enhances the ISGylation of p53 in a manner dependent on its transcription factor function, consequently amplifying the proteasome-dependent degradation of ISGylated p53 and promoting tumour cell growth [53]. The gene discussed is TP53; the disease is neoplasm.